MondayNov 09, 2020 12:03 pm

QualityStocksNewsBreaks – Cannabis Global Inc. (CBGL), NPE to Accelerate Expansion Plan Based on Expected Nationwide Cannabis Legalization

Cannabis Global (OTC: CBGL), a science-forward company developing CBD infusion technologies and products while investing in fast-growing segments of the cannabis industry, today announced an acceleration of its plans to expand operations in the cannabis sector in reaction to the significantly improved prospects for nationwide legalization of cannabis. According to the update, the strategic expansion will be conducted with Natural Plant Extract of California Inc (“NPE”). Cannabis Global recently acquired an 18.8% strategic investment stake in NPE, which holds a special Type 7 California cannabis manufacturing license, allowing for volatile extraction methodologies and cannabis product distribution anywhere in the state.…

Continue Reading

MondayNov 09, 2020 10:15 am

QualityStocksNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Q2 2021 Financial Results

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today released its unaudited condensed interim consolidated financial statements and management's discussion and analysis (“MD&A”) for the three and six months ended September 30, 2020 (“Q2 2021”). “Our quarter was framed with a sharp focus on PharmHouse. We provided debtor-in-possession financing to enable PharmHouse to remain operational as it commenced its CCAA process and our team has been working towards securing the best possible outcome for our shareholders,” said Narbe Alexandrian, president and CEO of Canopy Rivers. “While supporting PharmHouse has been our priority, we are confident…

Continue Reading

MondayNov 09, 2020 9:45 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Unveil Adaptive Design for Berubicin Phase 2 Clinical Trial in Nov. 12 Webinar

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced its plans to issue a video update at 4:30 p.m. ET on Nov. 12, 2020, to discuss the clinical trial design for its upcoming Phase 2 U.S. trial for Berubicin. CNSP’s lead drug candidate – Berubicin – is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive form of brain cancer, currently considered incurable. Robert LeBoyer, managing director of equity research at Ladenburg Thalmann & Co. Inc., will moderate the discussion.…

Continue Reading

FridayNov 06, 2020 11:16 am

QualityStocksNewsBreaks – CYBIN Inc. Completes Reverse Takeover Transaction

CYBIN (formerly Clarmin Explorations Inc.), a life sciences company initially focused on psychedelic pharmaceutical therapies, on Thursday announced it has completed its previously disclosed reverse takeover of Clarmin Explorations Inc. per the terms of an amalgamation agreement dated June 26, 2020, as amended on October 21, 2020. The agreement was among Cybin Corp., Clarmin and 2762898 Ontario Inc. (“SubCo”), a wholly-owned subsidiary of the company (the “reverse takeover”), in which the reverse takeover was completed by way of a “three-cornered” amalgamation pursuant to the provisions of the Business Corporations Act (Ontario). Through the reverse takeover, Cybin Corp. amalgamated with SubCo…

Continue Reading

FridayNov 06, 2020 10:22 am

QualityStocksNewsBreaks – Josemaria Resources Inc. (TSX: JOSE) (OTC: JOSMF) Files Technical Report for Argentina Copper-Gold Project

Josemaria Resources (TSX: JOSE) (OTC: JOSMF) on Thursday announced that it has filed a technical report prepared under National Instrument 43-101 Standards for Disclosure for Mineral Projects. The report is regarding the company's 100% owned Josemaria Copper-Gold Project, located in San Juan Province, Argentina. The technical report is being filed in support of the information contained in the company's news release dated October 19, 2020, entitled "Josemaria Resources Announces Positive Feasibility Study Showcasing a Conventional, Robust and Rapid Pay Back, Open Pit Copper-Gold Project," as well as in Josemaria's Material Change Report dated October 21, 2020. To view the full…

Continue Reading

ThursdayNov 05, 2020 1:16 pm

QualityStocksNewsBreaks – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) Secures $2.449M in Over-Subscribed Non-Brokered Private Placement

GoldHaven Resources (CSE: GOH) (OTCQB: ATUMF), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, today announced that it has closed a final tranche of an over-subscribed non-brokered private placement (the "offering"). GoldHaven secured aggregate total proceeds of $2,449,500 through closing of two tranches, previously announced on Oct. 16, Oct. 29 and Nov. 4, 2020, which consisted of a total of 12,247,500 aggregate units, each sold at a price of $0.20. The company intends to use net proceeds to commence an exploration program on its Maricunga Gold Belt projects, as well as for general working…

Continue Reading

ThursdayNov 05, 2020 12:52 pm

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Undertakes Marketing Analysis Ahead of Planned BudCars Expansion

Sugarmade (OTCQB: SGMD) today announced that, in anticipation of the planned expansion of the BudCars cannabis delivery service into new territories, it has undertaken an analysis of the efficacy of marketing spending relative to market size and population for the existing BudCars regional delivery footprint. According to the update, Sugarmade believes this may provide some insight into performance benchmarks and expectations related to the anticipated expansion into the North San Francisco Bay Area and the Wine Country counties, followed by Los Angeles. “We are very confident in the ROI associated with spending on BudCars marketing in connection with BudCars’ expansion,”…

Continue Reading

ThursdayNov 05, 2020 12:30 pm

QualityStocksNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Board Appointment of Dr. Khalid Islam

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients with a high unmet medical need, today announced the appointment of Dr. Khalid Islam to its board of directors. Dr. Islam was the chairman and CEO of Gentium S.p.A. (a Nasdaq-listed company; 2009-2014) where he led its transition to a profitable company that subsequently sold for US$1 billion. In addition, he is currently an advisor to the venture group Kurma Biofund (Paris), the chairman of the board for Fennec Pharmaceuticals Inc. (NASDAQ: FENC), Gain Therapeutics Inc. and Minoryx Therapeutics SL, and…

Continue Reading

ThursdayNov 05, 2020 12:21 pm

QualityStocksNewsBreaks – Cannabis Global Inc. (CBGL) Announces Filing of PCT Application to Protect Proprietary Cannabinoid Delivery System

Cannabis Global (OTC: CBGL), a cannabinoid and hemp-extract, science-forward company developing infusion and delivery technologies and products, has filed a Patent Cooperation Treaty (“PCT”) that seeks international protection of its proprietary cannabinoid infusion system for beverages, foods and consumer products. The PCT is aimed at seeking patent protections for inventions resulting from CBGL’s Project Varin research program. Specifically, the application relates to innovative methods for the creation of highly bioavailable and ultra-fast-acting cannabinoids for use in beverages, food, topicals and other applications. Noting that this technology is revolutionary, the company believes its breakthrough research could potentially result in substantial cost…

Continue Reading

ThursdayNov 05, 2020 11:19 am

QualityStocksNewsBreaks – InsuraGuest Technologies Inc. (TSX.V: ISGI) (OTC: IGSTF) Marks Milestone with Ability to Provide True Nationwide Coverage

InsuraGuest Technologies (TSX.V: ISGI) (OTC: IGSTF), an innovative insurtech provider, today announced that its wholly owned subsidiary InsuraGuest Insurance Agency LLC (“IG Agency”) has been approved as a resident surplus lines producer. According to the update, IG Agency is now licensed to offer surplus lines casualty and surplus lines property insurance in the state of Utah. With the new approval, IG Agency can be listed as the official producer for InsuraGuest’s specialized Hospitality Liability Master Policy and on all certificates the company issues to hotels and vacation rental properties. Additionally, IG Agency can now sell other non-admitted insurance products through…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered